Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
1.580
-0.100 (-5.95%)
At close: Apr 28, 2026, 4:00 PM EDT
1.530
-0.050 (-3.16%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Estrella Immunopharma Market Cap
Estrella Immunopharma has a market cap or net worth of $67.41 million as of April 28, 2026. Its market cap has increased by 104.83% in one year.
Market Cap
67.41M
Enterprise Value
70.30M
1-Year Change
104.83%
Ranking
Category
Stock Price
$1.58
Market Cap Chart
Since October 19, 2022, Estrella Immunopharma's market cap has increased from $1.78M to $67.41M, an increase of 3,692.25%. That is a compound annual growth rate of 180.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 71.68M | 21.66% |
| Dec 31, 2025 | 58.91M | 35.70% |
| Dec 31, 2024 | 43.41M | 11.11% |
| Dec 29, 2023 | 39.07M | 441.69% |
| Dec 30, 2022 | 7.21M | 305.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OS Therapies | 74.41M |
| Acrivon Therapeutics | 74.00M |
| Immutep | 73.66M |
| Actuate Therapeutics | 70.42M |
| Impact BioMedical | 70.36M |
| BeyondSpring | 70.11M |
| MediciNova | 67.43M |
| OnKure Therapeutics | 65.63M |